Related Experiment Videos
[Advances in growth impairment associated with pediatric respiratory diseases]
1Department of Pediatrics, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Insights
Pediatric respiratory diseases impair growth by affecting key biological pathways. Early monitoring and targeted treatments, including growth hormone, can improve outcomes for children with growth retardation.
Area of Science:
- Pediatric Pulmonology
- Endocrinology
- Growth Medicine
Background:
- Pediatric respiratory diseases are linked to impaired growth.
- Mechanisms include hypoxia, inflammation, metabolic issues, and medications affecting growth hormone-insulin-like growth factor axis.
Purpose of the Study:
- Summarize advances in understanding growth impairment in pediatric respiratory diseases.
- Discuss intervention strategies for optimizing growth outcomes.
Main Methods:
- Literature review of mechanistic advances.
- Analysis of growth impairment in obstructive sleep apnea, asthma, chronic lung injury, and recurrent respiratory infections.
- Discussion of intervention strategies.
Main Results:
- Respiratory diseases suppress growth hormone-insulin-like growth factor axis and peripheral signaling, causing growth retardation.
- Specific conditions discussed include obstructive sleep apnea, asthma, chronic lung injury, and recurrent respiratory infections.
Conclusions:
- Optimizing clinical management requires understanding pathophysiology.
- Interventions include growth monitoring, etiology-targeted therapy, and standardized growth hormone use.
- Management differs from idiopathic short stature.
Abstract:
Pediatric respiratory diseases are significantly associated with growth impairment. Through core pathways including chronic hypoxia, systemic inflammation, metabolic dysregulation, and pharmacological interference, these conditions suppress the growth hormone-insulin‑like growth factor axis and peripheral signaling, resulting in growth retardation. This article summarizes mechanistic advances regarding growth impairment in obstructive sleep apnea, asthma, chronic lung injury, and recurrent respiratory infections. Accordingly, it discusses intervention strategies encompassing growth monitoring, etiology‑targeted therapy, and the standardized use of growth hormone, while highlighting differences from the management of idiopathic short stature. The aim is to elucidate the underlying pathophysiology and provide evidence to optimize clinical management and improve growth outcomes.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pulmonary Cycle: Exhalation
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Breathing
Respiratory Syncytial Virus Disease